DongKook Pharmaceutical Co. Ltd
DongKook Pharmaceutical Co., Ltd. provides pharmaceutical products in South Korea and internationally. It produces active pharmaceutical ingredients, including propofol, streptokinase, and teicoplanin; disposable syringes; and pills, capsules, and ointments, as well as small volume parentral, large volume parentral, and lyophilized injectable drug injections. The company also offers Teicon, Durak… Read more
DongKook Pharmaceutical Co. Ltd (086450) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.015x
Based on the latest financial reports, DongKook Pharmaceutical Co. Ltd (086450) has a cash flow conversion efficiency ratio of 0.015x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩11.38 Billion) by net assets (₩743.40 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
DongKook Pharmaceutical Co. Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how DongKook Pharmaceutical Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
DongKook Pharmaceutical Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of DongKook Pharmaceutical Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Telecom Argentina S.A
PINK:TCMFF
|
0.099x |
|
Xinlei Compressor Co. Ltd. A
SHE:301317
|
N/A |
|
AGARWALEYE
NSE:AGARWALEYE
|
0.050x |
|
ENDUR ASA NK 050
F:4ZT0
|
N/A |
|
Inst Diagnosti
SN:INDISA
|
0.078x |
|
Jiangsu Jiuwu Hi-Tech Co Ltd
SHE:300631
|
0.067x |
|
Qingdao Daneng Environmental Protection Equipment Co Ltd
SHG:688501
|
-0.018x |
|
BOE Varitronix Limited
PINK:VARXF
|
0.113x |
Annual Cash Flow Conversion Efficiency for DongKook Pharmaceutical Co. Ltd (2013–2024)
The table below shows the annual cash flow conversion efficiency of DongKook Pharmaceutical Co. Ltd from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩678.98 Billion | ₩76.09 Billion | 0.112x | +54.50% |
| 2023-12-31 | ₩576.17 Billion | ₩41.79 Billion | 0.073x | -11.00% |
| 2022-12-31 | ₩501.94 Billion | ₩40.91 Billion | 0.082x | -17.03% |
| 2021-12-31 | ₩454.57 Billion | ₩44.65 Billion | 0.098x | -31.63% |
| 2020-12-31 | ₩411.37 Billion | ₩59.11 Billion | 0.144x | -24.96% |
| 2019-12-31 | ₩362.87 Billion | ₩69.48 Billion | 0.191x | +80.48% |
| 2018-12-31 | ₩313.02 Billion | ₩33.21 Billion | 0.106x | -2.29% |
| 2017-12-31 | ₩263.94 Billion | ₩28.66 Billion | 0.109x | -34.62% |
| 2016-12-31 | ₩237.32 Billion | ₩39.41 Billion | 0.166x | +22.14% |
| 2015-12-31 | ₩199.62 Billion | ₩27.14 Billion | 0.136x | +5.59% |
| 2014-12-31 | ₩176.57 Billion | ₩22.74 Billion | 0.129x | +5.20% |
| 2013-12-31 | ₩162.24 Billion | ₩19.86 Billion | 0.122x | -- |